Global Polymerase Chain Reactions (Standard, RT, Digital) Devices, Reagents and Uses Market Research Report 2022 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

The global polymerase chain reactions (pcr) devices, reagents and uses market is expected to grow from $5.14 billion in 2021 to $5.56 billion in 2022 at a compound annual growth rate (CAGR) of 8.2%. The market is expected to grow to $6.97 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%.

Major players in the Polymerase Chain Reactions (PCR) devices and reagents market are Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Becton, Dickinson and Company, Abbott, bioMerieux SA, Agilent Technologies, QIAGEN N.V, Siemens Healthcare GmbH (Siemens AG), and Fluidigm Corporation.

The Polymerase Chain Reactions (PCR) devices and reagents market consists of sales of PCR devices and reagents and related services. The services include only installation and maintenance services offered by equipment manufacturers. Polymerase Chain Reactions (PCR) devices are designed to aid scientists in producing multiple copies of specific DNA segments.

The main products of Polymerase Chain Reactions (PCR) devices and reagents are instruments, reagents, consumables. An instrument is a tool or device for doing a particular kind of work. The instruments used are standards PCR, rt-PCR, digital PCR. The various end-users are pharmaceutical and biotechnology industries, clinical diagnostics labs and hospitals, academics, and research organizations.

The growing prevalence of infectious diseases across the world is driving the polymerase chain reactions devices and reagents market. Polymerase chain reactions devices are used in clinical laboratories to detect the presence of infectious diseases. In a report published by the World Health Organization, it was reported that around 17 million people are killed in a year due to infectious diseases.

Also, the same report stated that 30 new infectious diseases have emerged in the last 20 years. According to the National Centre for Health Statistics, 15.5 million people in the US visited a physician, due to an infectious disease. Such instances are increasing the demand for clinical diagnostic services and thereby driving the polymerase chain reactions devices and reagents market.

The emergence of alternatives is a major restraint on the growth of polymerase chain reaction devices and the reagents market. In the field of DNA sequencing, the polymerase chain reaction technique has competitors like Next Generation Sequencing and Sanger Sequencing which provide similar utility as PCR devices and reagents and even better results in some cases, thus increasing the competition in the market and thereby limiting PCR devices and reagents growth.

For instance, in a study conducted, 138 FFPE non-small lung cancer samples were examined, with assays developed through Sanger, Next Generation Sequencing, and polymerase chain reaction techniques. All three assays were compared and it was reported that assays developed by NGS and QPCR exhibited similar analytical sensitivity, simplicity, and high level of concordance.

Moreover, it was found that NGS assays proved to be better than qPCR in displaying more accurate information about allele sequence, mutation frequency, and the detection of non-hotspot mutations. This emergence of alternative procedures is expected to restrain the growth of the market during the forecast period.

Companies in the polymerase chain reaction devices and reagents market are increasingly focusing on Digital PCR due to its higher accuracy compared to conventional PCR. Conventional PCR is an end-point investigation that is not fully quantified because the enhanced item is distinguished by agarose gel electrophoresis.

Digital PCR expands on customary PCR enhancement and fluorescent-probe- based identification techniques to give a comprehensive evaluation of nucleic acids without the requirement for standard bends. The companies investing in digital polymerase chain reaction technology include BioRad Technologies, Atlas Genetics, OriGene Technologies STST-Diagnostica, Ugen Tec, and Genesis Healthcare Company.

Key Topics Covered:

1. Executive Summary

2. Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Characteristics

3. Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Size And Growth

3.1. Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Historic Market, 2016 - 2019, $ Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Forecast Market, 2019 - 2023F, 2026F, 2031F, $ Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Segmentation

4.1. Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market, Segmentation By Product, Historic and Forecast, 2016-2019, 2023F, 2026F, 2031F, $ Billion

• Instruments
• Reagents
• Consumables

4.2. Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market, Segmentation By End User, Historic and Forecast, 2016-2019, 2023F, 2026F, 2031F, $ Billion

• Pharmaceutical and biotechnology industries
• Clinical Diagnostics labs and hospitals
• Academics and research organization

4.3. Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market, Segmentation By Instruments, Historic and Forecast, 2016-2019, 2023F, 2026F, 2031F, $ Billion

• Standard PCR
• RT-PCR
• Digital PCR

5. Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market Regional And Country Analysis

5.1. Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market, Split By Region, Historic and Forecast, 2016-2019, 2023F, 2026F, 2031F, $ Billion

5.2. Global Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Market, Split By Country, Historic and Forecast, 2016-2019, 2023F, 2026F, 2031F, $ Billion

Companies Mentioned

• Bio-Rad Laboratories
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific
• Becton
• Dickinson and Company
• Abbott
• bioMerieux SA
• Agilent Technologies
• QIAGEN N.V.
• Siemens Healthcare GmbH (Siemens AG)
• Fluidigm Corporation
• SYGNIS Pharma AG;
• Takara Bio
• Cepheid
• lontech Laboratories
• Eppendorf
• Fluidigm
• GE Healthcare
• Kapa Biosystems
• Maxim Biotech
• Takara Bio Inc
• Promega
• RainDance Technologies
• Affymetrix Inc.
• Beckman Coulter
• Enzo Life Science

For more information about this report visit https://www.researchandmarkets.com/r/r9kpnp

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900